MGO One Seven’s Abiomed Inc ABMD Stock Holding History

MGO One Seven’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-80	Closed	-$26K	–	1778
2018 Q4	$26K	Buy	+80	New	+$27.8K	0.01%	842

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MGO One Seven's ABMD Position: Q1 2019 in Review

MGO One Seven sold out of Abiomed Inc (ABMD) in Q1 2019, closing a stake of 80 shares — an estimated $26K sold.

MGO One Seven first reported a position in ABMD in Q4 2018 and held it in 1 quarter. The position peaked at $26K in Q4 2018. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

MGO One Seven reported no remaining Abiomed Inc position as of Q1 2019 after selling out during the quarter.
MGO One Seven sold 80 Abiomed Inc shares in Q1 2019, an estimated $26K.
MGO One Seven first reported a position in Abiomed Inc in Q4 2018 and held it in 1 quarter.
MGO One Seven's Abiomed Inc position peaked at $26K in Q4 2018.
559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.